Trial of Botulinum Toxin for Isolated or Essential Head Tremor
Trial of Botulinum Toxin for Isolated or Essential Head Tremor
About this item
Full title
Author / Creator
Btx-HT Study Group , Marques, Ana , Pereira, Bruno , Simonetta-Moreau, Marion , Castelnovo, Giovanni , De Verdal, Marie , Fluchère, Frédérique , Laurencin, Chloé , Degos, Bertrand , Tir, Mélissa , Kreisler, Alexandre , Blanchet-Fourcade, Geneviève , Guehl, Dominique , Colin, Olivier , Poujois, Aurelia , Sangla, Sophie , Tatu, Laurent , Derost, Philippe , Gayraud, Dominique , Tranchant, Christine , Amarantini, David , Devos, David , Rascol, Olivier , Corvol, Jean-Christophe , Durif, Franck and Rieu, Isabelle
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Injection of botulinum toxin into each splenius capitis muscle at baseline and week 12 was more effective than placebo in reducing the severity of essential head tremor over 18 weeks. Effects waned at 24 weeks.
Alternative Titles
Full title
Trial of Botulinum Toxin for Isolated or Essential Head Tremor
Authors, Artists and Contributors
Author / Creator
Marques, Ana
Pereira, Bruno
Simonetta-Moreau, Marion
Castelnovo, Giovanni
De Verdal, Marie
Fluchère, Frédérique
Laurencin, Chloé
Degos, Bertrand
Tir, Mélissa
Kreisler, Alexandre
Blanchet-Fourcade, Geneviève
Guehl, Dominique
Colin, Olivier
Poujois, Aurelia
Sangla, Sophie
Tatu, Laurent
Derost, Philippe
Gayraud, Dominique
Tranchant, Christine
Amarantini, David
Devos, David
Rascol, Olivier
Corvol, Jean-Christophe
Durif, Franck
Rieu, Isabelle
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_04305836v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04305836v1
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2304192
